| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/02/2023 | 11.6% | Piper Sandler | $150 → $155 | Reiterates | Neutral → Neutral |
| 10/30/2023 | 18.8% | Oppenheimer | → $165 | Upgrades | Perform → Outperform |
| 07/28/2023 | 29.6% | Mizuho | $170 → $180 | Maintains | Buy |
| 07/27/2023 | 26% | RBC Capital | $165 → $175 | Maintains | Outperform |
| 07/27/2023 | 19.52% | Barclays | $163 → $166 | Maintains | Overweight |
| 07/27/2023 | 8% | Piper Sandler | → $150 | Reiterates | Neutral → Neutral |
| 07/27/2023 | 27.44% | Keybanc | $160 → $177 | Maintains | Overweight |
| 07/25/2023 | 6.56% | Rosenblatt | → $148 | Reiterates | Buy → Buy |
| 07/24/2023 | 18.8% | RBC Capital | $158 → $165 | Maintains | Outperform |
| 07/14/2023 | 17.36% | Barclays | $152 → $163 | Maintains | Overweight |
| 06/21/2023 | 8.72% | Stifel | → $151 | Reiterates | Buy → Buy |
| 06/14/2023 | 8% | Piper Sandler | → $150 | Initiates Coverage On | → Neutral |
| 05/24/2023 | 19.52% | BMO Capital | → $166 | Initiates Coverage On | → Outperform |
| 05/17/2023 | 22.4% | Mizuho | $165 → $170 | Maintains | Buy |
| 05/17/2023 | 13.76% | RBC Capital | → $158 | Reiterates | Outperform → Outperform |
| 05/17/2023 | 6.56% | Rosenblatt | → $148 | Reiterates | Buy → Buy |
| 04/27/2023 | 13.76% | RBC Capital | $155 → $158 | Maintains | Outperform |
| 04/27/2023 | 9.44% | Barclays | $150 → $152 | Maintains | Overweight |
| 04/24/2023 | 0.8% | Citigroup | $147 → $140 | Maintains | Neutral |
| 04/14/2023 | 6.56% | Rosenblatt | → $148 | Reiterates | → Buy |
| 02/02/2023 | 22.4% | Loop Capital | $160 → $170 | Maintains | Buy |
| 02/02/2023 | -6.4% | JP Morgan | $128 → $130 | Maintains | Neutral |
| 02/02/2023 | 18.8% | Mizuho | $155 → $165 | Maintains | Buy |
| 02/02/2023 | 8% | Barclays | $144 → $150 | Maintains | Overweight |
| 02/02/2023 | 6.56% | Rosenblatt | $142 → $148 | Maintains | Buy |
| 02/02/2023 | 15.2% | Keybanc | $155 → $160 | Maintains | Overweight |
| 01/30/2023 | 11.6% | RBC Capital | $140 → $155 | Maintains | Outperform |
| 01/27/2023 | 5.84% | Citigroup | $135 → $147 | Maintains | Neutral |
| 01/26/2023 | 18.8% | Baird | $150 → $165 | Maintains | Outperform |
| 01/23/2023 | 11.6% | Keybanc | → $155 | Upgrades | Sector Weight → Overweight |
| 01/11/2023 | 3.68% | Barclays | $148 → $144 | Maintains | Overweight |
| 01/11/2023 | 11.6% | Berenberg | → $155 | Initiates Coverage On | → Buy |
| 01/05/2023 | 2.24% | Rosenblatt | $138 → $142 | Maintains | Buy |
| 11/18/2022 | 11.6% | Mizuho | $135 → $155 | Maintains | Buy |
| 11/17/2022 | 6.56% | Barclays | $135 → $148 | Maintains | Overweight |
| 11/03/2022 | 0.8% | RBC Capital | $135 → $140 | Maintains | Outperform |
| 11/03/2022 | -0.64% | Rosenblatt | $146 → $138 | Maintains | Buy |
| 10/24/2022 | 3.68% | Baird | $153 → $144 | Maintains | Outperform |
| 09/19/2022 | -7.84% | JP Morgan | → $128 | Reinstates | → Neutral |
| 08/17/2022 | 11.6% | Wolfe Research | → $155 | Initiates Coverage On | → Outperform |
| 07/28/2022 | -2.8% | RBC Capital | $130 → $135 | Maintains | Outperform |
| 07/28/2022 | -6.4% | Mizuho | $120 → $130 | Maintains | Buy |
| 07/27/2022 | — | Oppenheimer | Initiates Coverage On | → Perform | |
| 07/21/2022 | 5.12% | Rosenblatt | $156 → $146 | Maintains | Buy |
| 07/19/2022 | -13.6% | Mizuho | $135 → $120 | Maintains | Buy |
| 04/28/2022 | -13.6% | Barclays | $141 → $120 | Maintains | Overweight |
| 04/28/2022 | -2.8% | Mizuho | $125 → $135 | Maintains | Buy |
| 04/25/2022 | -6.4% | RBC Capital | $150 → $130 | Maintains | Outperform |
| 12/14/2021 | -0.64% | JP Morgan | $175 → $138 | Downgrades | Overweight → Neutral |
| 11/04/2021 | 22.4% | Rosenblatt | $160 → $170 | Maintains | Buy |
| 10/18/2021 | 18.8% | Mizuho | $175 → $165 | Maintains | Buy |
| 10/13/2021 | 7.28% | Barclays | $161 → $149 | Maintains | Overweight |
| 06/08/2021 | 13.04% | Rosenblatt | → $157 | Initiates Coverage On | → Buy |
| 04/19/2021 | 18.8% | RBC Capital | $145 → $165 | Maintains | Outperform |
| 04/16/2021 | 15.92% | Barclays | $145 → $161 | Maintains | Overweight |
| 01/28/2021 | 4.4% | RBC Capital | $130 → $145 | Upgrades | Sector Perform → Outperform |
| 12/16/2020 | -10% | Needham | $100 → $125 | Maintains | Buy |
| 12/09/2020 | -6.4% | JP Morgan | $88 → $130 | Upgrades | Underweight → Overweight |
| 10/30/2020 | -61.84% | Credit Suisse | $52 → $53 | Maintains | Neutral |
| 09/16/2020 | -20.8% | Loop Capital | → $110 | Initiates Coverage On | → Buy |
| 07/30/2020 | -30.88% | Citigroup | $91 → $96 | Maintains | Neutral |
| 07/30/2020 | -24.4% | Rosenblatt | $95 → $105 | Maintains | Buy |
| 07/30/2020 | -35.92% | RBC Capital | $82 → $89 | Maintains | Sector Perform |
| 07/20/2020 | -32.32% | Barclays | $82 → $94 | Maintains | Overweight |
| 07/16/2020 | -28% | Stifel | $85 → $100 | Upgrades | Hold → Buy |
| 06/10/2020 | -31.6% | Mizuho | $80 → $95 | Maintains | Buy |
| 06/05/2020 | -28% | Needham | → $100 | Initiates Coverage On | → Buy |
| 05/01/2020 | -42.4% | Mizuho | $75 → $80 | Maintains | Buy |
| 04/30/2020 | -46% | Citigroup | $68 → $75 | Maintains | Neutral |
| 02/19/2020 | — | Baird | Assumes | → Outperform | |
| 01/24/2020 | -42.4% | Citigroup | $75 → $80 | Maintains | Neutral |
| 01/23/2020 | -35.2% | Stifel | $80 → $90 | Maintains | Hold |
| 01/23/2020 | -24.4% | Baird | $95 → $105 | Maintains | Outperform |
| 01/23/2020 | -38.08% | Wedbush | $77 → $86 | Maintains | Neutral |
| 01/23/2020 | -31.6% | Mizuho | $80 → $95 | Maintains | Buy |
| 11/04/2019 | -41.68% | Barclays | → $81 | Reinstates | → Overweight |
| 10/07/2019 | -38.8% | Barclays | $96 → $85 | Maintains | Overweight |
| 10/02/2019 | -46% | Citigroup | $89 → $75 | Maintains | Neutral |
| 08/22/2019 | -40.24% | Rosenblatt | → $83 | Initiates Coverage On | → Buy |
| 07/25/2019 | -28% | Mizuho | $120 → $100 | Maintains | Buy |
| 07/25/2019 | — | Guggenheim | Downgrades | Buy → Neutral | |
| 07/25/2019 | -38.8% | RBC Capital | $110 → $85 | Downgrades | Outperform → Sector Perform |
| 07/25/2019 | -39.52% | Stifel | $105 → $84 | Downgrades | Buy → Hold |
| 07/25/2019 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 07/22/2019 | — | Citigroup | Initiates Coverage On | → Neutral | |
| 04/25/2019 | — | B of A Securities | Downgrades | Neutral → Underperform | |
| 04/25/2019 | -20.8% | Deutsche Bank | $115 → $110 | Maintains | Buy |
| 04/25/2019 | -28% | Wedbush | $104 → $100 | Downgrades | Outperform → Neutral |
| 04/25/2019 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 04/12/2019 | -13.6% | Mizuho | → $120 | Initiates Coverage On | → Buy |
| 04/10/2019 | -20.08% | Keybanc | → $111 | Reinstates | → Overweight |
| 01/16/2019 | — | Deutsche Bank | Initiates Coverage On | → Buy | |
| 12/19/2018 | -24.4% | Stifel | → $105 | Initiates Coverage On | → Buy |
What is the target price for PTC (PTC)?
The latest price target for PTC (NASDAQ: PTC) was reported by Piper Sandler on November 2, 2023. The analyst firm set a price target for $155.00 expecting PTC to rise to within 12 months (a possible 11.60% upside). 37 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for PTC (PTC)?
The latest analyst rating for PTC (NASDAQ: PTC) was provided by Piper Sandler, and PTC reiterated their neutral rating.
When is the next analyst rating going to be posted or updated for PTC (PTC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PTC, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PTC was filed on November 2, 2023 so you should expect the next rating to be made available sometime around November 2, 2024.
Is the Analyst Rating PTC (PTC) correct?
While ratings are subjective and will change, the latest PTC (PTC) rating was a reiterated with a price target of $150.00 to $155.00. The current price PTC (PTC) is trading at is $138.89, which is out of the analyst's predicted range.